Managing the Dual-Disease Burden: Ho Chi Minh City Respiratory Society and Gia Dinh People’s Hospital Sign Strategic Three-Year MoUs with Pfizer Vietnam to Strengthen Clinical Capacity and Preventive Care

Key Development

In response to epidemiological shifts across Vietnam, the Ho Chi Minh City Respiratory Society and Gia Dinh People’s Hospital have executed two separate three-year strategic Memoranda of Understanding (MoUs) with Pfizer Vietnam.

The non-commercial partnership focuses on advancing continuous medical education (CME), standardizing clinical workflows, enhancing early diagnostic precision, and scaling preventive counseling to address Vietnam’s growing “dual-disease burden”—characterized by escalating non-communicable diseases (NCDs) alongside ongoing challenges in managing complex infectious pathogens.

Core Strategic Pillars Across Agreements:

1. Collaboration with the HCMC Respiratory Society (President Assoc. Prof. Dr. Tran Van Ngoc):

   • Focuses on continuous medical education (CME) and updating clinical practice guidelines for chronic airway diseases, including Asthma and Chronic Obstructive Pulmonary Disease (COPD), alongside acute exacerbation management protocols.

   • Integrates risk-stratified preventive counseling into daily outpatient clinical workflows for physicians and nursing staff.

2. Collaboration with Gia Dinh People’s Hospital (Director Assoc. Prof. Dr. Nguyen Hoang Hai):

   • Expands internal medicine training (cardiovascular diseases, stroke, oncology) and infectious disease management, extending standardized practices across southern regional hospital networks.

   • Enhances Antimicrobial Stewardship (AMS) and antifungal management to address severe bloodstream infections and invasive fungal diseases.

3. Statutory Alignment & Academic Independence:

   • Program academic content is led independently by medical societies and hospital leadership based on scientific evidence, devoid of commercial product promotion.

   • Directly aligns with the national public health priorities outlined in the Law on Disease Prevention No. 114/2025/QH15 (effective July 11, 2026), anchoring a shift toward “proactive prevention centered around the patient.”

Why It Matters

• Epidemiological Intersection of NCDs and Infectious Risks:

  • Non-communicable diseases currently account for 80% of all annual deaths in Vietnam.

  • Patients with underlying chronic comorbidities face elevated risks of severe outcomes during acute infections: COPD patients aged $>60$ years face a 4-fold higher risk of pneumococcal pneumonia; COPD patients aged $>50$ years face a 9.6 to 9.7-fold elevated risk of RSV-related hospitalization.

• High Clinical Mortality from Sepsis & Invasive Fungal Infections: A prospective cohort study in Vietnam (2018–2020) documented an overall mortality rate of 52% among bloodstream infection patients with positive blood cultures. Concurrently, invasive fungal infections among immunocompromised, asthmatic, and COPD cohorts represent major critical care challenges.

• Extrapulmonary Cognitive Decline in COPD: Approximately 32% of COPD patients exhibit cognitive impairment, reaching 56% upon advanced neuropsychological evaluation. Early diagnosis and comprehensive management are essential to prevent long-term cognitive deterioration.

Healthcare Insight Analysis

From the perspective of Healthcare Insight, the three-year strategic engagement between HCMC Respiratory Society, Gia Dinh People’s Hospital, and Pfizer Vietnam illustrates Public-Private Partnerships (PPP) in Dual-Disease Burden Management.

Metropolitan healthcare systems like Ho Chi Minh City reflect the “development paradox”: urbanization and demographic aging drive up long-term chronic healthcare expenditures, while hospital-acquired infections and antimicrobial resistance (AMR) compound the severity of chronic disease exacerbations.

This collaboration addresses three operational priorities:

1. Transitioning from Acute Triage to Proactive Outpatient Prevention: Equipping frontline healthcare professionals to deliver preventive immunization counseling (pneumococcal, influenza, RSV) and environmental risk management during routine visits, reducing acute ICU admissions.

2. Institutionalizing Antimicrobial Stewardship (AMS): Supporting clinical teams in optimizing antimicrobial and antifungal regimens, directly targeting the $52\%$ sepsis mortality baseline and limiting the emergence of multidrug-resistant pathogens.

3. Hub-and-Spoke Regional Knowledge Dissemination: Leveraging Gia Dinh People’s Hospital as an academic training hub to cascade standardized clinical pathways and case-based learning to lower-tier district facilities, mitigating referral bottlenecks at tertiary hospitals.

Market Implications

1. Expanding Adult & Comorbid Immunization Pathways: Elevated clinical focus on pneumococcal and RSV vulnerabilities in COPD and diabetic patients will support adult immunization adoption across hospital-affiliated clinics and vaccination centers.

2. Reinforcing Diagnostic Stewardship for Anti-Infectives: Heightened focus on severe sepsis management will encourage hospitals to institutionalize blood culture and fungal biomarker testing prior to broad-spectrum antimicrobial administration.

3. Expanding Non-Commercial Big Pharma Clinical Collaborations: Demonstrates a model for multinational pharmaceutical firms to partner with leading public hospitals through academic, non-promotional medical education programs in Vietnam.

Strategic Framework Matrix: Dual Burden Medical Collaboration (2026–2029)

Focus Vector	Epidemiological Baseline & Initiative Targets	Clinical & Systemic Impact
Non-Communicable Disease (NCD) Burden	Causes 80% of total annual deaths in Vietnam	Prioritizes early detection & active prevention.
Pneumococcal Risk in COPD	4x higher risk in patients aged $>60$ years	Embeds vaccine-preventable counseling in clinics.
RSV Hospitalization Risk in COPD	9.6x – 9.7x higher risk in patients aged $>50$	Improves recognition of viral respiratory triggers.
Bloodstream Infection Mortality	52% mortality rate in positive blood cultures	Strengthens Antimicrobial Stewardship (AMS) protocols.
Extrapulmonary COPD Complications	32% – 56% exhibit cognitive impairment	Broadens holistic management beyond airway symptoms.
Partnership Duration	3 Years (2026 – 2029)	Independent academic CME & clinical capacity building.

Source: https://suckhoedoisong.vn/tang-nang-luc-y-te-day-manh-du-phong-truoc-ganh-nang-benh-tat-kep-169260816162207454.htm